medigraphic.com
Instituto Nacional de Salud Pública

2024, Number 6

<< Back Next >>

salud publica mex 2024; 66 (6)

Impact of the Covid-19 pandemic on the epidemiological weekly report surveillance system of Mexico

Delgado-Juárez GC, Bernal-Silva S, Méndez-González KJ, Contreras-Ibáñez CC, Comas-García A

Language: English
References: 25
Page: 831-841
PDF size: 427.45 Kb.


ABSTRACT

Objective. To quantify the impact of the Covid-19 pandemic on the reporting rate of notifiable diseases in Mexico between 2020-2022. Materials and methods. Data were obtained from the Weekly Epidemiological Bulletin of the Ministry of Health of the Government of Mexico for the period 2014-2022. One hundred thirty-two endemic channels were created by calculating the weekly percentiles 25th, 50th, and 75th for the period 2014-2019. Subsequently, data recorded between 2020-2022 were compared, determining if more or fewer cases were reported than expected. Prepandemic data tendency was considered. Results. The study included 132 diseases from 2014 to 2019, reporting an annual median of 49 947 420 cases. In comparison with the data reported between 2014-2019, there was a decrease in the reported cases of 39.9% in 2020, 19.7% in 2021, and 25.7% in 2022. Thirty-one diseases increased their reporting, while 101 decreased. Of the diseases that increased, seven were sexually transmitted, 13 were infectious, and five were chronic-metabolic. Conclusions. The pandemic has significantly impacted the landscape of mandatory notifiable diseases in Mexico. The pandemic has led to modifications in the epidemiological trends of disease reporting.


REFERENCES

  1. Colchero MA, Moreno-Aguilar LA, Bautista-Arredondo S. The Covid-19cascade of care in Mexico: symptoms, positivity, and health care seekingdecisions amid the pandemic. Salud Publica Mex. 2021;63(6):734-42.https://doi.org/10.21149/12822

  2. Colchero MA, Gómez R, Pineda-Antúnez CJ, Bautista-ArredondoSA. Health care utilization during the Covid-19 pandemic Mexico: thecascade of care. Salud Publica Mex. 2021;63(6):743-50. https://doi.org/10.21149/12894

  3. Doubova SV, Lesli HH, Kurk ME, Pérez-Cuevas R, Arsenault C. Disruptionin essential health services in Mexico during COVID-19: an interruptedtime series analysis of health information system data. BMJ GlobalHealth. 2021;6:e006204. https://doi.org/10.1136/bmjgh-2021-006204

  4. Li H, Ling F, Zhang S, Liu Y, Wang C, Lin H, et al. Comparison of 19major infectious diseases during Covid-19 epidemic and previous yearsin Zhejiang implications, for prevention and measure. BMC Infect Dis.2022;22:296. https://doi.org/10.1186/s12879-022-07301-w

  5. Liu W, Wang R, Li Y, Zhao S, Chen Y, Zhao Y. The indirect impacts ofnonpharmacological Covid-19 control measures on other infectiousdiseases in Yinchuan, Northwest China: a time series study. BMC Pub Heal.2023;23:1089. https://doi.org/10.1186/s12889-023-15878-3

  6. Li G, Tang D, Song B, Wang C, Qunshan S, Xu C, et al. Impact of theCovid-19 pandemic on partner relationship and sexual and reproductivehealth: Cross-sectional, online survey study. J Med Internet Res.2020;22(8):e20961. https://doi.org/10.2196/20961

  7. Sentís A, Prats-Uribe A, López-Corbeto E, Montoro-Fernandez M,Nomah DK, Garcia de Olalla P, et al. The impact of Covid-19 pandemicon sexually transmitted infections surveillance data: incidence drop orartefact?. BMC Public Health. 2021;21:1637. https://doi.org/10.1186/s12889-021-11630-x

  8. Lörincz K, Mezneric FA, Jobbágy A, Kiss N, Madarász M, Belvon L,et al. STIs during the Covid-19 pandemic in Hungary: Gonorrhea as apotential indicator of sexual behavior. Int J Environ Res Public Health.2022;19(15):9627. https://doi.org/10.3390/ijerph19159627

  9. Melamed OC, Selby P, Taylor VH. Mental health and obesity duringthe Covid-19 Pandemic. Curr Obes Rep. 2022;11:23-1. https://doi.org/10.1007/S13679-021-00466-6

  10. González-Block MA, Reyes-Morales H, Cahuana-Hurtado L, BalandránA, Méndez E. Mexico: Health System Review. Health Syst Transit.2020;22(2):1-222 [cited May 26, 2023]. Available from: https://www.insp.mx/avisos/mexico-health-system-review-2020

  11. Gobierno de México. Covid-19 México. México: Gobierno de México[cited May 26, 2023]. Available from: https://datos.covid-19.conacyt.mx/

  12. Gobierno de México. Dirección General de Epidemiología, BoletínEpidemiológico Sistema Nacional de Vigilancia Epidemiológica, SistemaÚnico de Información. México: Gobierno de México [cited May 26, 2023].Available from: https://www.gob.mx/salud/acciones-y-programas/direcciongeneral-de-epidemiologia-boletin-epidemiologico

  13. Gobierno de México. Dirección General de Epidemiología, HistóricoBoletín Epidemiológico. México: Gobierno de México [cited May 26,2023]. Available from: https://www.gob.mx/salud/acciones-y-programas/historico-boletin-epidemiologico

  14. Comas-Garcia A, Delgado-Juárez CG, Bernal-Silva S, Méndez-González KJ, Contreras-Ibañez CC. Supplementary figures andtables. Figshare 2024 [cited May 26, 2023]. https://doi.org/10.6084/m9.figshare.25213550.v1

  15. Hennis AJM, Coates A, Del Pino S, Ghidinelli M, Gomez-Ponce deLeon R, Bolastig E, et al. Covid-19 and inequities in the Americas: Lessonslearned and implications for essential health services. Rev Panam SaludPublica. 2021;45:e130. https://doi.org/10.26633/RPSP.2021.130

  16. Mendonza-Popoca CÚ, Suárez-Morales M. Reconversión hospitalariaante la pandemia de COVID-19. Rev Mex Anest. 2020;43(2):151-6. https://doi.org/10.35366/92875

  17. Chang AY, Cullen MR, Harrington RA, Barry M. The impact of novel coronavirusCovid-19 on noncommunicable disease patients and health systems: areview. J Inter Med. 2021;289(4):450-62. https://doi.org/10.1111/joim.13184

  18. Melamed OC, Selby P, Taylor VH. Mental health and obesity duringthe Covid-19 Pandemic. Curr Obes Rep. 2022;11:23-31. https://doi.org/10.1007/s13679-021-00466-6

  19. Bright A, Glynn-Robinson AJ, Kane S, Wright R, Saul N. The effectof Covid-19 public health measures on nationally notifiable diseases inAustralia: preliminary analysis. Comm Dis Intell. 2020:44. https://doi.org/10.33321/cdi.2020.44.85

  20. Geng MJ, Zhang HY, Yu LJ, Lv CL, Wang T, Che TL, et al. Changes innotifiable infectious disease in China during the Covid-19 pandemic. NatCommun. 2021;12:6923. https://doi.org/10.1038/s41467-021-27292-7

  21. Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, RebolledoPA, Cuapio A, Villapol S. More than 50 long-term effects of COVID-19:a systematic review and meta-analysis. Sci Rep. 2021;11:16144. https://doi.org/10.1038/s41598-021-95565-8

  22. Stefan N, Birkenfeld AL, Schulze MB. Global pandemics interconnected– obesity, impaired metabolic health and COVID-19. Nat Rev Endocrinol.2021;17:135-49. https://doi.org/10.1038/s41574-020-00462-1

  23. Barquera S, Campos-Nonato I, Aguilar-Salinas C, Lopez-Ridaura R,Arredondo A, Rivera-Dommarco J. Diabetes in Mexico: cost and managementof diabetes and its complications and challenges for health policy.Global Health. 2013;9:3. https://doi.org/10.1186/1744-8603-9-3

  24. Bautista-Arredondo S, Vargas-Flores A, Moreno-Aguilar LA, ColcheroMA. Health services utilization in Mexico: the 2022 cascade of care. SaludPublica Mex. 2023;65(supp 1):S15-S22. https://doi.org/10.21149/14813

  25. Hauveline P. Global and national declines in life expectancy: Anend-of-2021 assessment. Popul Dev Rev. 2022;48(1):31-50. https://doi.org/10.1111/padr.12477




2020     |     www.medigraphic.com